NASDAQ
Biodexa Pharmaceuticals plc - American Depositary Shares (BDRX)
♥ 607 Thanks from members
Biodexa Pharmaceuticals (BDRX) faces severe volatility and dilution concerns following a 10,000:1 reverse split and £25m share authority, balanced against clinical trial progress for eRapa in Familial Adenomatous Polyposis.